BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2018
View Archived Issues
LogicBio Therapeutics begins program for genome-editing therapy for methylmalonic acidemia
Read More
CFDA clears HG-146 to enter clinical trials for multiple myeloma
Read More
Intrommune Therapeutics launches financing campaign to support development of INT-301
Read More
Shionogi recaps progress of fourth quarter of fiscal 2017
Read More
SPRINT-MS trial: phase II results of ibudilast treatment in progressive multiple sclerosis
Read More
EVOLVE-MS-1 trial shows ALKS-8700 effects in patients with relapsing remitting multiple sclerosis
Read More
First patient dosed in the phase I/II trial of KB-103
Read More
Promising in vivo results for EP-055, a potential nonhormonal male contraceptive
Read More
Mainline Biosciences submits pre-IND meeting information package for MLB-1707
Read More
ROCK and PKC inhibitor AR-13503 in development for ocular disorders
Read More
Novel liver X receptor beta agonists divulged by Merck & Co.
Read More
Nimbus Lakshmi patents novel TYK2 inhibitors
Read More
Lundbeck identifies novel phosphodiesterase PDE1 inhibitors
Read More
Positive topline data from phase I trial of prophylactic CMV vaccine candidate VBI-1501
Read More
Novel P2X purinoceptor 7 antagonists discovered at Shionogi
Read More
Prelude Therapeutics discovers PRMT5 inhibitors
Read More
Patient recruitment ongoing in phase I trial of PF-06821497
Read More
Novel PTP-2C inhibitors discovered at DE Shaw Research, Relay Therapeutics
Read More
Pharmasum Therapeutics identifies novel DYRK inhibitors
Read More
MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A
Read More
Phosphodiesterase PDE4 inhibitors patented byTakeda
Read More
Lilly to acquire ARMO BioSciences
Read More
FDA identifies deficiencies during NDA review of Methylene Blue MMX
Read More
Phase I study of AVB-S6-500 demonstrates proof of mechanism
Read More
Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication
Read More
SymBio enters joint research agreement with Keio University to evaluate Treakisym for SLE
Read More
CARB-X supports Talis' development of diagnostics to detect chlamydia and gonorrhea
Read More
KemPharm reports topline data from human abuse potential trial with KP-415 prodrug
Read More
FDA advisory committee votes in favor of Waylivra for familial chylomicronemia syndrome
Read More
Phase III GALATHEA trial of Fasenra in COPD does not meet primary endpoint
Read More
Lipimetix sublicenses Apo E mimetic peptide platform to Anji
Read More
New phase II proof-of-concept trial studies IXT-m200 in methamphetamine users
Read More